ELPISCIENCE BIOPHARMACEUTICALS
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. The company has a robust pipeline of globally innovative molecules, covering wide range of targets in immuno-oncology. Founded and managed by a team of biopharma industry leaders and scientists, Elpiscience endeavors to advance at least one innovative molecule into the clinic each year to benefit cancer patients worldwide.
ELPISCIENCE BIOPHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.elpiscience.com
Total Employee:
101+
Status:
Active
Contact:
+86 21 50651310
Email Addresses:
[email protected]
Total Funding:
260 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apache Mobile Non Scaleable Content Euro Sectigo SSL DigiCert SSL Sectigo Domain SSL
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
BioShin
BioShin is a clinical stage biopharmaceutical company.
Curevo
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Entera Bio
Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel drug delivery platform.
GeneMedicine
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
Harbour Biomed
Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.
ImmuneOnco Biopharma
ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Employees Featured
Founder
Investors List
Greater Bay Area Homeland Development Fund
Greater Bay Area Homeland Development Fund investment in Series C - Elpiscience Biopharmaceuticals
Maison Capital
Maison Capital investment in Series C - Elpiscience Biopharmaceuticals
Superstring Capital
Superstring Capital investment in Series C - Elpiscience Biopharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Elpiscience Biopharmaceuticals
CDH Investments
CDH Investments investment in Series C - Elpiscience Biopharmaceuticals
Dyee Capital
Dyee Capital investment in Series C - Elpiscience Biopharmaceuticals
Zero2IPO
Zero2IPO investment in Series C - Elpiscience Biopharmaceuticals
Oriza Holdings
Oriza Holdings investment in Series C - Elpiscience Biopharmaceuticals
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Elpiscience Biopharmaceuticals
CDH Investments
CDH Investments investment in Series B - Elpiscience Biopharmaceuticals
Official Site Inspections
http://www.elpiscience.com
- Host name: catl.com
- IP address: 203.107.45.167
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Elpiscience Biopharmaceuticals"
Elpiscience
Elpiscience has a robust pipeline of globally innovative cancer immunotherapies, covering a wide range of oncology targets. Through internal R&D expertise and partnerships with global …See details»
Elpiscience Biopharmaceuticals - Crunchbase
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. The company has a robust pipeline of globally innovative molecules, …See details»
Our Vision - About - Elpiscience
Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for cancer patients worldwide. The company’s innovative …See details»
Elpiscience (Suzhou) Biopharma, Ltd. - Drug pipelines, …
Elpiscience’s Co-Founder and CEO Darren Ji will also be sharing his perspective on the BioPharma Business in the Asia Pacific Region: Huge Markets, Great Opportunities panel at the conference. ... The statistics for drugs in the …See details»
Our Values - Career - Elpiscience
Together, we live Elpiscience’s values as we advance scientific innovation and develop transformative medicines that improve cancer patients’ lives. Our Values. Ownership, Courage and Rigor constitute the core values at Elpiscience. ...See details»
Elpiscience | VentureRadar
Elpiscience has a pipeline of more than 10 innovative molecules in discovery, covering a wide range of targets with a particular focus on innate immunity and tumor microenvironment. Its …See details»
Elpiscience and Astellas Enter into Research …
Dec 28, 2023 SHANGHAI and SUZHOU, China and TOKYO, Dec. 28, 2023 /PRNewswire/ -- Elpiscience Biopharma, Ltd. (Chairman and CEO: Darren Ji, MD, Ph.D., "Elpiscience") and Astellas Pharma Inc. (TSE: 4503, President and …See details»
Elpiscience Biopharmaceuticals Company Profile - Craft
Elpiscience is a biopharmaceutical company specializing in cancer immunotherapy. It has a pipeline of innovative molecules in discovery, covering a range of targets with a particular …See details»
Elpiscience Biopharmaceuticals - Contacts, Employees, Board …
Organization. Elpiscience Biopharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. …See details»
Elpiscience Biopharmaceuticals - Funding, Financials, Valuation
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Elpiscience and Astellas Enter into Research …
Dec 28, 2023 Elpiscience is also eligible to receive single-digit to lower double-digit percent royalty payments on net sales for licensed products per each program. Darren Ji , MD, Ph.D., Chairman and CEO ...See details»
Immuno-Oncology Approach - Science - Elpiscience
Elpiscience has also assembled a global clinical team with a broad range of expertise from designing and leading first-in-human studies to executing large-scale global registration trials. …See details»
News | Astellas Pharma Inc.
Dec 28, 2023 Shanghai and Suzhou, TOKYO, December 28, 2023 - Elpiscience Biopharma, Ltd. (Chairman and CEO: Darren Ji, MD, Ph.D., “Elpiscience”) and Astellas Pharma Inc. (TSE: …See details»
Elpiscience Announces First Patient Dosed in US Phase I Clinical …
Jan 20, 2022 SHANGHAI, China and SUZHOU, China and GERMANTOWN, Md., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical …See details»
Hongtao Lu - CSO, Co-Founder @ Elpiscience ... - Crunchbase
Hongtao Lu is currently co-founder and Chief Scientific Officer (CSO) of Elpiscience Biopharmaceuticals, Inc. Trained as an immunologist and a 20-year industry veteran, he has …See details»
Elpiscience and Astellas Enter into Research ... - Business Wire
Dec 28, 2023 Elpiscience will receive up to US $37 million, including the upfront payment and license option fees. In addition, Elpiscience will receive research funding from Astellas to …See details»
Social Recruitment - Join Us - Career - Elpiscience
Demonstrate an Elpiscience culture of courage, ownership, and rigor. If you are a like-minded person who seeks challenges and excitement, we invite you to join us. ... think independently …See details»
Elpiscience Announces First Patient Dosed in US Phase I
Jan 20, 2022 Elpiscience received U.S. Food and Drug Administration (FDA) IND clearance for ES002 in September 2021. “We are very pleased to see ES002 enter clinical trial testing in the …See details»
Elpiscience Announces First Patient Dosed in US Phase I Clinical …
Jan 20, 2022 SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical …See details»
Pipeline Overview - Elpiscience
The following pipeline consists of programs and platform that are of strategic importance for Elpiscience to deliver the next generation of cancer immunotherapies. Asset TargetSee details»